Cellectis (CLLS) Other Operating Expenses (2015 - 2026)

Cellectis (CLLS) recorded quarterly Other Operating Expenses of $63000.0 in Q1 2026, up 119.69% quarter-over-quarter from -$320000.0 in Q4 2025, and down 85.21% on a YoY basis from $426000.0 in Q1 2025.

Cellectis (CLLS) Other Operating Expenses (2015 - 2026) Analysis & Trends

Cellectis' Other Operating Expenses history runs 12 years deep, the most recent figure standing at $63000.0 for Q1 2026.

  • In Q1 2026, Other Operating Expenses fell 85.21% year-over-year to $63000.0; the TTM figure through Mar 2026 stood at $275000.0 (down 77.82% YoY), while the FY2025 annual figure was $849000.0, changed 0.0% from the prior year.
  • Other Operating Expenses was $63000.0 for Q1 2026 at Cellectis, up from -$320000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $839000.0 in Q4 2022 to a low of -$1.2 million in Q4 2023.
  • Historically, Other Operating Expenses has averaged $102294.1 across 5 years, with a median of $63000.0 in 2026.
  • The sharpest annual moves came in 2022 and 2023: Other Operating Expenses jumped 11885.71% in 2022, then slumped 3009.52% in 2023.
  • A 5-year view of Other Operating Expenses shows it stood at $839000.0 in 2022, then plunged by 243.5% to -$1.2 million in 2023, then surged by 96.1% to -$47000.0 in 2024, then tumbled by 580.85% to -$320000.0 in 2025, then soared by 119.69% to $63000.0 in 2026.
  • The last three Other Operating Expenses figures came in at $63000.0 (Q1 2026), -$320000.0 (Q4 2025), and $154000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Cellectis 17.40 Bn 17.21 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 63,000.00
Dec 31, 2025 -320,000.00
Sep 30, 2025 154,000.00
Jun 30, 2025 378,000.00
Mar 31, 2025 426,000.00
Dec 31, 2024 -47,000.00
Sep 30, 2024 175,000.00
Jun 30, 2024 686,000.00
Mar 31, 2024 35,000.00
Dec 31, 2023 -1.20 Mn
Sep 30, 2023 -12,000.00
Jun 30, 2023 528,000.00
Mar 31, 2023 -611,000.00
Dec 31, 2022 839,000.00
Sep 30, 2022 -125,000.00
Jun 30, 2022 753,000.00
Mar 31, 2022 21,000.00
Dec 31, 2021 7,000.00
Sep 30, 2021 18,000.00
Jun 30, 2021 150,000.00